The world you see depends upon the news you get. ®
Merck to Present New Data From GARDASIL®9 Studies Reinforcing the Importance of Gender-Neutral HPV Vaccination in Adults Up to Age 45 at the International Papillomavirus Conference (IPVC) 2024
by |
RAHWAY, N.J.–(BUSINESS WIRE)—- $MRK #MRK–Merck to Present New Data From GARDASIL®9 Studies Reinforcing the Importance of Gender-Neutral HPV Vaccination in Adults Up to Age 45 at IPVC 2024.
